Baud M - Search Results

1

Optimization of small-cell lung cancer chemotherapy with heparin: a comprehensive retrospective study of 239 patients treated in a single specialized center.

Lebeau B, Baud M, Masanes MJ, Febvre M, Mokhtari T, Chouaïd C. Lebeau B, et al. Among authors: baud m. Chemotherapy. 2011;57(3):253-8. doi: 10.1159/000328014. Epub 2011 Jun 6. Chemotherapy. 2011. PMID: 21654168

2

Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancer.

Lebeau B, Chouaïd C, Baud M, Masanès MJ, Febvre M. Lebeau B, et al. Among authors: baud m. Lung Cancer. 2010 Feb;67(2):188-93. doi: 10.1016/j.lungcan.2009.03.024. Epub 2009 Apr 24. Lung Cancer. 2010. PMID: 19394109 Clinical Trial.

3

Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.

Urban T, Bedin A, Baud M, Chouaid C, Febvre M, Lebeau B. Urban T, et al. Among authors: baud m. Lung Cancer. 1996 Feb;14(1):109-17. doi: 10.1016/0169-5002(95)00516-1. Lung Cancer. 1996. PMID: 8696714 Clinical Trial.

4

[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].

Lebeau B, Urban T, Baud M, Collon T, Le Guen Y, Febvre M, Touboul E. Lebeau B, et al. Among authors: baud m. Rev Mal Respir. 2001 Sep;18(4 Pt 1):405-9. Rev Mal Respir. 2001. PMID: 11547248 French.

5

[Medico economic analysis in first line chemotherapy in advanced lung cancer].

Joly AC, Austruy-Chalendard G, Camps S, Baud M, Nérot A, Bégué D, Chouaid C, Tilleul P. Joly AC, et al. Among authors: baud m. Therapie. 2006 Mar-Apr;61(2):101-7. doi: 10.2515/therapie:2006026. Therapie. 2006. PMID: 16886701 French.

6

[A prospective study of quality of life and treatment of chemotherapy-induced anaemia in lung cancer].

Borget I, Tilleul P, Baud M, Granghaud A, Iglesias E, Chouaid C. Borget I, et al. Among authors: baud m. Rev Mal Respir. 2007 Jan;24(1):41-7. Rev Mal Respir. 2007. PMID: 17268364 French.

7

Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy.

Tan Sean P, Chouaid C, Hettler D, Baud M, Hejblum G, Tilleul P. Tan Sean P, et al. Among authors: baud m. Curr Med Res Opin. 2009 Jun;25(6):1455-60. doi: 10.1185/03007990902918156. Curr Med Res Opin. 2009. PMID: 19419340

8

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).

Chouaid C, Le Caer H, Locher C, Dujon C, Thomas P, Auliac JB, Monnet I, Vergnenegre A; GFPC 0504 Team. Chouaid C, et al. BMC Cancer. 2012 Jul 20;12:301. doi: 10.1186/1471-2407-12-301. BMC Cancer. 2012. PMID: 22817667 Free PMC article. Clinical Trial.

9

[Adjuvant chemotherapy of non-small cell lung cancer: Tolerance of combined cisplatin-pemetrexed therapy].

Gauvain C, Crequit P, Rousseau-Bussac G, Ganoun A, Baud M, Chouaid C. Gauvain C, et al. Among authors: baud m. Rev Mal Respir. 2014 Nov;31(9):817-21. doi: 10.1016/j.rmr.2013.10.646. Epub 2013 Dec 30. Rev Mal Respir. 2014. PMID: 25433586 French.

10

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis.

Borget I, Tilleul P, Baud M, Joly AC, Daguenel A, Chouaid C. Borget I, et al. Among authors: baud m. Lung Cancer. 2006 Mar;51(3):369-76. doi: 10.1016/j.lungcan.2005.10.024. Epub 2006 Jan 4. Lung Cancer. 2006. PMID: 16388876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters